Page 78 - Screening for Cervical Cancer: Systematic Evidence Review

References

cancer: a worldwide perspective. International biological study on
cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796-802.

15. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM.
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for
rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in
cervical scrapings. J Clin Microbiol. 1997;35:791-795.

16. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and
partner characteristics are the predominant risk factors for genital human
papillomavirus infection in young women. J Infect Dis. 1996;174(4):679-689.

17. Dillner J, Kallings I, Brihmer C, et al. Seropositivities to human papillomavirus types 16,
18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J
Infect Dis. 1996;173(6):1394-1398.

18. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer.
1995;76:1888-1901.

19. Meijer CJ, Helmerhorst TJ, Rozendaal L, van der Linden JC, Voorhorst FJ, Walboomers
JM. HPV typing and testing in gynaecological pathology: has the time come?
Histopathology. 1998;33:83-86.

20. Rosenthal DL, Acosta D, Peters RK. Computer-assisted rescreening of clinically
important false negative cervical smears using the PAPNET Testing System. Acta
Cytologica. 1996;40:120-126.

21. Cuzick J, Sasieni P, Davies P, et al. Systematic Review of the Role of Human
Papillomavirus Testing Within a Cervical Cancer Screening Program. Health
Technol Assess. 1999;3:I-IV and 1-196.

22. Park T, Fujiwara H, Wright TC. Molecular biology of cervical cancer and its precursors.
Cancer. 1995;76:1902-1913.

23. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med.
1997;102:3-8.

24. Hildesheim A, Hadjimichael O, Schwartz PE, et al. Risk factors for rapid-onset cervical
cancer. Am J Obstet Gynecol. 1999;180:571-577.

25. Janerich DT, Hadjimichael O, Schwartz PE, et al. The screening histories of women with
invasive cervical cancer, Connecticut. Am J Public Health. 1995;85:791-794.

26. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of
cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol.
2000;96:219-223.

27. Martin-Hirsch P, Lilford R, Jarvis G, Kitchener HC. Efficacy of cervical-smear collection

84